Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Multiverse Investment Fund I is a private venture capital fund focused on early to clinical-stage investments primarily in life sciences, materials science, and technology. Its healthcare/life science portfolio includes companies developing advanced cellular therapies and bioparticle-based delivery systems for major unmet medical needs such as cancer immunotherapy and COVID-related ARDS. Portfolio companies have reached preclinical through clinical trial stages with some programs receiving special regulatory dispensations during the COVID pandemic.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Multiverse Investment Fund I.